ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Bexsero, Injektionssuspension - 
65730003 GlaxoSmithKline AG
Bexsero, Injektionssuspension23.11.2017
  23.11.2017
Meningococcus B, Multicomponent Vaccine (J07AH09) 
WHO-DDD 
08.08. 
08.08. 
B  
Yes 
IP 
78.14Yes
    
10 %106.20
  
7680657300031Impfstoffe
 ● 
Composition
proteinum fusionatum NHBA neisseriae meningitidis B 50 µg, proteinum NadA neisseriae meningitidis B 50 µg, proteinum fusionatum fHbp neisseriae meningitidis B 50 µg, vesicula membranae exterioris (OMV) ex Neisseria meningitidis B (Stamm: NZ98/254) 25 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, histidinum, natrii chloridum, saccharum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.2 mg.
Packungsbestandteile
Injection suspension 
  
 
Active AgentDose
Proteinum Fusionatum fhbp Neisseriae Meningitidis B50µg / 0.5ml
Proteinum Fusionatum nhba Neisseriae Meningitidis B50µg / 0.5ml
Proteinum nada Neisseriae Meningitidis B50µg / 0.5ml
Vesicula Membranae Exterioris (Omv) ex Neisseria Meningitidis b (Stamm: Nz98/254)25µg / 0.5ml
BAG: Active AgentDose
Neisseria Meningitidis b Outer Membrane Vesicle25 mcg
Proteinum Fusionatum fhbp Neisserii Meningitidii B50 mcg
Proteinum Fusionatum nhba Neisserii Meningitidii B50 mcg
Proteinum nada Neisserii Meningitidii B50 mcg
 
Inactive agentsDose
Alumine0.5mg / 0.5ml
Histidine 
Sodium Chloride 
Saccharum 
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home